These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 28076843
1. Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes. Benzina S, Beauregard AP, Guerrette R, Jean S, Faye MD, Laflamme M, Maïcas E, Crapoulet N, Ouellette RJ, Robichaud GA. Oncotarget; 2017 Feb 14; 8(7):12052-12066. PubMed ID: 28076843 [Abstract] [Full Text] [Related]
2. Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors. Harquail J, LeBlanc N, Landry C, Crapoulet N, Robichaud GA. J Mammary Gland Biol Neoplasia; 2018 Sep 14; 23(3):177-187. PubMed ID: 30032344 [Abstract] [Full Text] [Related]
3. miRNAs 484 and 210 regulate Pax-5 expression and function in breast cancer cells. Harquail J, LeBlanc N, Ouellette RJ, Robichaud GA. Carcinogenesis; 2019 Aug 22; 40(8):1010-1020. PubMed ID: 30605519 [Abstract] [Full Text] [Related]
4. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells. Castillo LF, Tascón R, Lago Huvelle MR, Novack G, Llorens MC, Dos Santos AF, Shortrede J, Cabanillas AM, Bal de Kier Joffé E, Labriola L, Peters MG. Oncotarget; 2016 Sep 13; 7(37):60133-60154. PubMed ID: 27507057 [Abstract] [Full Text] [Related]
5. Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin. Liu X, Tian X. Med Sci Monit; 2021 Mar 15; 27():e929832. PubMed ID: 33716295 [Abstract] [Full Text] [Related]
6. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW. Breast Cancer Res; 2017 Jul 27; 19(1):86. PubMed ID: 28750639 [Abstract] [Full Text] [Related]
7. Pax-5 Inhibits Breast Cancer Proliferation Through MiR-215 Up-regulation. Leblanc N, Harquail J, Crapoulet N, Ouellette RJ, Robichaud GA. Anticancer Res; 2018 Sep 27; 38(9):5013-5026. PubMed ID: 30194145 [Abstract] [Full Text] [Related]
9. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines. Martowicz A, Spizzo G, Gastl G, Untergasser G. BMC Cancer; 2012 Oct 30; 12():501. PubMed ID: 23110550 [Abstract] [Full Text] [Related]
10. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development. Wu K, Zeng J, Zhou J, Fan J, Chen Y, Wang Z, Zhang T, Wang X, He D. Urol Oncol; 2013 Nov 30; 31(8):1751-60. PubMed ID: 22421353 [Abstract] [Full Text] [Related]
11. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer. Lee HK, Lee DS, Park JC. BMC Cancer; 2015 Mar 10; 15():113. PubMed ID: 25879941 [Abstract] [Full Text] [Related]
12. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL. Urol Oncol; 2014 Aug 10; 32(6):855-63. PubMed ID: 24968949 [Abstract] [Full Text] [Related]
13. Influence of autocrine growth hormone on NF-κB activation leading to epithelial-mesenchymal transition of mammary carcinoma. Baskari S, Govatati S, Madhuri V, Nallabelli N, K PM, Naik S, Poornachandar, Balka S, Tamanam RR, Devi VR. Tumour Biol; 2017 Oct 10; 39(10):1010428317719121. PubMed ID: 29022487 [Abstract] [Full Text] [Related]
14. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis. Karicheva O, Rodriguez-Vargas JM, Wadier N, Martin-Hernandez K, Vauchelles R, Magroun N, Tissier A, Schreiber V, Dantzer F. Oncotarget; 2016 Sep 27; 7(39):64109-64123. PubMed ID: 27579892 [Abstract] [Full Text] [Related]
15. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells. Sehrawat A, Singh SV. Cancer Prev Res (Phila); 2011 Jul 27; 4(7):1107-17. PubMed ID: 21464039 [Abstract] [Full Text] [Related]
16. NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer. Kong C, Wang C, Wang L, Ma M, Niu C, Sun X, Du J, Dong Z, Zhu S, Lu J, Huang B. PLoS One; 2011 Jul 27; 6(7):e22666. PubMed ID: 21829474 [Abstract] [Full Text] [Related]
17. The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells. Wang B, Lindley LE, Fernandez-Vega V, Rieger ME, Sims AH, Briegel KJ. PLoS One; 2012 Jul 27; 7(7):e41355. PubMed ID: 22844464 [Abstract] [Full Text] [Related]
18. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines. Alexopoulou AN, Leao M, Caballero OL, Da Silva L, Reid L, Lakhani SR, Simpson AJ, Marshall JF, Neville AM, Jat PS. Breast Cancer Res; 2010 Jul 27; 12(4):R51. PubMed ID: 20642837 [Abstract] [Full Text] [Related]
19. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers. Wendt MK, Taylor MA, Schiemann BJ, Sossey-Alaoui K, Schiemann WP. Breast Cancer Res; 2014 Mar 11; 16(2):R24. PubMed ID: 24618085 [Abstract] [Full Text] [Related]
20. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells. Yu JM, Sun W, Hua F, Xie J, Lin H, Zhou DD, Hu ZW. Cancer Lett; 2015 Sep 01; 365(2):190-200. PubMed ID: 26049022 [Abstract] [Full Text] [Related] Page: [Next] [New Search]